It was also reported that GSK3β inhibitors suppress Bcl2-mediated and α5/β1-integrin-dependent cell survival pathways, thereby eliminating primitive leukemia progenitor/stem cells [134,137,138]. This evidence concerns the gene GSK3B and leukemia.